Given IL-10’s role in inhibiting neuroinflammation linked to diabetic cognitive dysfunction, the study suggests that let-7c-5p might exacerbate MCI in T2DM patients by reducing IL-10, affecting neuroinflammation pathways. This evidence concerns the gene IL10 and type 2 diabetes mellitus.